Description
Retatrutide (GLP-3) 15mg is a synthetic triple receptor agonist peptide studied in preclinical and clinical research for its interactions with GLP-1, GIP, and glucagon receptor (GLP-1/GIP/GCGR) binding and downstream signaling pathway analysis. Available exclusively for licensed research and laboratory use.
Research Background
Retatrutide has been investigated in peer-reviewed studies examining triple incretin receptor binding affinity, pancreatic signaling modulation, and associated metabolic pathway mechanisms. References are provided for informational purposes relating to published scientific literature.
Product Specifications
- Classification: Triple GLP-1/GIP/GCGR receptor agonist peptide
- Purity: 99%+ verified by LCMS
- Format: Lyophilized powder
- Storage: -20 degrees C, protected from light
- CAS Number: 2381306-68-7
For research use only. Not for human or animal consumption. Not a drug, food, or cosmetic. Must be handled by licensed, qualified professionals in a controlled laboratory setting.
Research Resources
For research purposes only. Not for human use.
